Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immune Pharmaceuticals Inc IMNPQ

Healthcare Biotechnology
Immune Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. The company's lead program, bertilimumab is a first-in-class, human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. By blocking eotaxin-1, bertilimumab may prevent the migration and... see more

Bullboard (EXPM:IMNPQ)

View:
1 2 Next
Comment by G1945Von Jun 05, 2020 7:53am

RE:RE:IMNP: IMMUNE PHARMS INC SEC Filing

Immune Pharma - anti-eotaxin-1 antibody: Alexion has entered into an asset purchase agreement with Immune Pharma to acquire an anti-eotaxin-1 antibody for potential development in inflammatory ...more  
273
Discussion
Comment by G1945Von May 25, 2019 1:36pm

RE:IMNP: IMMUNE PHARMS INC SEC Filing

https://www.immunepharma.com/news-events/press-releases/detail/180/immune-pharmaceuticals-announces-leadership-transition G1945V
103
Discussion
Post by G1945Von Jan 17, 2019 2:17pm

IMNP: IMMUNE PHARMS INC SEC Filing

IMNP: IMMUNE PHARMS INC SEC Filing - Securities Registration Statement (S-1/A) January 17, 2019 Read the full filing now
160
Discussion
Post by G1945Von Dec 18, 2018 10:20am

IMMUNE Engages EXTERA PARTNERS

News Release:  Still, hope for IMNP that it will deliver. jmo G1945V _________________________________________________________________________________________________ Immune Pharmaceuticals ...more  
177
Post by G1945Von Nov 09, 2018 2:47am

IMNP-Seeking Alpha

IMNP: IMMUNE PHARMS INC SEC Filing - Proxy Statement (definitive) (DEF 14A) November 8, 2018 https://seekingalpha.com/filings/pdf/13050844.pdf  
137
Post by G1945Von Sep 11, 2018 10:44am

Sep. 11, 2018 8:20 AM ET|By Mamta Mayani, SA News Editor

Immune Pharmaceuticals' Bertilimumab receives Fast Track designation for the treatment of bullous pemphigoid The FDA has granted Fast Track designation to Immune Pharmaceuticals'  ...more  
118
Post by G1945Von Jul 31, 2018 4:01am

OTC Disclosure & News Service-Press Release 07-30-18

https://www.otcmarkets.com/stock/IMNP/news/Immune-Pharmaceuticals-Receives-Positive-Opinion-for-Orphan-Drug-Designation-in-the-European-Union-for-Bertilimumab-for-?id=199333
136
Post by G1945Von Jul 30, 2018 8:51am

Important to know that,

IMNP...may now be a non-qualified investments inside a registered plan.((i.e. RSP, RIF LIRA LRIF LIF RESP or TFSA) because of the delisting from nasdaq.  https://www.fin.gc.ca/act/fim-imf/dse ...more  
177
Comment by G1945Von Jul 23, 2018 1:15pm

RE:NEWS PROVIDED BY WuXi Biologics

Suzanne Elvidge@suzannewriter PUBLISHED July 12, 2018 WuXi adds to its dealmaking hot streak. https://www.biopharmadive.com/news/wuxi-adds-to-its-dealmaking-hot-streak/527399/ G1945V
115
Discussion
Post by G1945Von Jul 21, 2018 7:57am

Immune to hold Special Meeting of Stockholders 08/22/2018

https://globenewswire.com/news-release/2018/07/17/1538301/0/en/Immune-Pharmaceuticals-Announces-Filing-of-Proxy-Statement-for-Reverse-Stock-Split.html
122
Comment by G1945Von Jul 11, 2018 11:00am

RE:RE:NEWS PROVIDED BY WuXi Biologics

ICO has stolen the limelight at the moment for its Phase 1 Oral Amphotericin B ( Oral Amp B) study clinical trial when safety results were announced.   There is not much else that I can ...more  
186
Discussion
Comment by sovy888on Jul 10, 2018 9:06am

RE:NEWS PROVIDED BY WuXi Biologics

why isn't anyone on this board excited about these great news??? just wondering...
140
Discussion
Post by G1945Von Jul 09, 2018 12:25pm

NEWS PROVIDED BY WuXi Biologics

WuXi Biologics collaborates with Bioasis May 21, 2018, for the Development and Manufacturing of Bioasis' lead investigational candidate to treat brain cancer and now with Immune Pharmaceuticals ...more  
219
Discussion
Post by G1945Von Jun 13, 2018 9:48am

NASDAQ-Listing Determination

https://globenewswire.com/news-release/2018/06/08/1518984/0/en/Immune-Pharmaceuticals-Announces-Receipt-of-Nasdaq-Listing-Determination.html
175
Post by G1945Von May 25, 2018 4:29am

Immune Pharmaceuticals Provides a Pipeline Update

https://globenewswire.com/news-release/2018/05/23/1510715/0/en/Immune-Pharmaceuticals-Provides-a-Pipeline-Update.html
142
1 2 Next